JOURNAL OF CHEMICAL RESEARCH 2011 353
Scheme 3
127.8, 128.5, 133.9 (C-1′, C-1″), 137.4, 146.7 (C-4′, C-4″), 149.8
(C-3′, C-3″). HRMS Calcd for C34H42NO6(M+NH4+): 560.3007.
Found: 560.3012.
Threo-( )-10b had consistently larger Rf values than those of
the corresponding meso-10a, and each pair were easily sepa-
rated by flash column chromatography over silica gel. The
data for the configuration of threo-( )-10b was in agreement
with that reported in the literature.15
The 4-hydroxyl group of threo-( )-10b was protected with
benzyl chloride to afford the compound 4. Threo-( )-4 was
treated with DDQ in acetic acid to give the 2-aryl-tetrahydro-
furan lignan 5.16 After acylation of 5 with 4-benzyloxybenzoic
acid, and then hydrogenation, natural product agastinol 1 was
obtained (Scheme 3). The spectroscopic data of agastinol was
in agreement with the literature.8
In summary, we have developed an efficient and practical
synthesis of a tetrahydrofuran lignan based on Stobbe reaction
to construct the skeleton of lignan, oxidation with DDQ to give
the tetrahydrofuran ring. Agastinol, a potential anti-apoptotic
agent, was obtained for the first time by this route.
4,4′-Dibenzyloxy-3,3′-dimethoxybenzyl-9-hydroxy-7,9′-epoxylig-
nan (5): DDQ (0.9 g, 4 mmol) was added to a solution of compound 4
(1.1 g, 2 mmol) in glacial acetic acid. The mixture was stirred for 5 h.
The reaction mixture was poured onto crushed ice and extracted with
EtOAc (20 mL). The organic layer was washed with a saturated solu-
tion of NaHSO3 (3 × 20 mL) and a saturated solution of NaHCO3
(3 × 20 mL). The extract was dried over MgSO4 and concentrated
in vacuo. Flash column chromatography of the residue gave ( )-
dihydrosesamin 5 as a colourless oil (0.5 g, 46%). IR (KBr/cm−1):
3448, 2936, 1595, 1512, 1456, 1226, 1023. 1H NMR (CDCl3,
500 MHz) δ: 2.76 (dd, 1H, J = 13.0, 11.0 Hz, H-7α), 2.76−2.87 (m,
1H, H-8′), 3.01−3.09 (m, 1H, H-8), 3.22 (dd, 1H, J = 13.5, 5.5 Hz,
H-7β), 3.80 (s, 6H, 2 × OCH3), 4.06 (dd, 1H, J = 8.5, 6.5 Hz, H-9α),
4.17 (dd, 1H, J = 11.0, 6.5 Hz, H-9′α), 4.25 (dd, 1H, J = 11.0, 7.0 Hz,
H-9′β), 4.30 (dd, 1H, J = 8.5, 6.5 Hz, H-9β), 5.15 (s, 4H, 2 ×ArCH2O),
5.28 (d, 1H, J = 6.0 Hz, H-7′), 6.90−7.45 (m, 16H, ArH). 13C NMR
(CDCl3, 125 MHz) δ: 33.1 (C-9), 42.3 (C-8), 52.5 (C-8’), 56.0 (2 ×
OCH3), 60.8 (C-9’), 71.2 (ArCH2), 72.7 (C-7), 82.5 (C-7’), 108.7,
111.2, 112.1, 112.4, 117.9, 120.5, 127.1, 127.7, 128.4, 132.3, 134.9,
137.3, 147.4, 148.2, 148.8, 148.9. HRMS Calcd for C34H40NO6
(M+NH4+):558.2851. Found: 558.2847.
Agastinol (1): A solution of 5 (0.54 g, 1 mmol) in dry CH2Cl2
(20 mL) was added dropwise to a solution of 4-benzyloxybenzoic acid
(0.23 g, 1 mmol), DCC (2.1 g, 10 mmol) and DMAP (0.13 g, 1 mmol)
in dry CH2Cl2 (20 mL) at 0 °C for 2 h under nitrogen. After stirring
the mixture overnight at room temperature, the reaction mixture was
filtered and the solvent was distilled. The residue was dissolved in
20 mL MeOH and was stirred under a hydrogen atmosphere for 7 h in
the presence of 10% Pd/C (0.6 g). The reaction mixture was filtered
through a pad of Celite, and then the solvent was removed in vacuo.
Flash column chromatography of the residue gave an amorphous
powder of Agastinol 1 (0.42 g, 87%) (no melting point). IR (KBr,
cm−1) v: 3452, 2918, 1720, 1590, 1507, 1455, 1152. 1H NMR (CD3OD,
500 MHz) δ: 2.62 (dd, 1H, J = 13.5, 10.5 Hz, H-7α), 2.65−2.73 (m,
1H, H-8′), 2.81−2.89 (m, 1H, H-8), 2.93 (dd, 1H, J = 13.5, 5.5 Hz,
H-7β), 3.74 (dd, 1H, J = 8.5, 6.5 Hz, H-9α), 3.77 (s, 3H, OCH3), 3.82
(s, 3H, OCH3), 4.02 (dd, 1H, J = 8.5, 6.5 Hz, H-9β), 4.38 (dd, 1H, J =
11.0, 6.5 Hz, H-9′α), 4.60 (dd, 1H, J = 11.0, 7.5 Hz, H-9′β), 4.85 (d,
1H, J = 6.5 Hz, H-7′), 6.70−7.83 (m, 10H, ArH). 13C NMR (CD3OD,
Experimental
Melting points were taken on Gallenkamp melting point apparatus
and are uncorrected. Infrared spectra were recorded on a Nicolet
NEXUS 670 FT−IR. The 1H NMR and 13C NMR spectra were recorded
on a Brucker AM−500 MHz spectrometers. Mass spectra were
recorded on a ZAB−HS spectrometer. HRMS were obtained on
a Bruker Daltonics APEXII47e spectrometer. Flash column chroma-
tography was performed on silica gel (200–300 mesh) and TLC
inspections on silica gel GF254 plates.
Threo-( )-Secoisolariciresinol(10b) was synthesised according to
the procedure which has been described previously.17
Threo-( )-2,3-bis(4′-benzyloxy-3′-methoxybenzyl)-1,4-butanediol
(4): Following the procedure described for the preparation of 2,
and starting with the diester 10b (3.6 g, 10 mmol), compound 4 was
obtained as a yellow oil (4.8 g, 89%). IR (KBr/cm−1): 3383, 2921,
1
1521, 1245, 1037, 928. H NMR (CDCl3, 500 MHz) δ: 1.85−1.95
(m, 2H, 2 × ArCH2CH), 2.62−2.67 (m, 4H, 2 × ArCH2CH), 3.54−3.56
(m, 2H, CH2OH), 3.60−3.62 (m, 2H, CH2OH), 3.80 (s, 6H, 2 × OCH3),
5.13 (s, 4H, 2 × ArCH2O), 6.61−6.71 (m, 6H, ArH), 7.27−7.37 (m,
10H, ArH). 13C NMR (CDCl3, 125 MHz) δ: 35.9 (C-3, C-4), 45.0
(C-7′, C-7″), 56.1 (2 × OCH3), 63.4 (C-1, C-4), 71.3 (2 × ArCH2O),
113.0 (C-2′, C-2″), 114.4 (C-5′, C-5″), 121.0 (C-6′, C-6″), 127.3,